BML Capital Management LLC Makes New $3.05 Million Investmen

BML Capital Management LLC acquired a new position in Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Get Rating) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 1,110,605 shares of the company’s stock, valued at approximately $3,054,000. Verrica Pharmaceuticals accounts for approximately 2.9% of BML Capital Management […]

Related Keywords

Canada , , Bml Capital Management , Quarter For Verrica Pharmaceuticals , Nasdaq , Capital Management , Verrica Pharmaceuticals Profile , Cubist Systematic Strategies , Verrica Pharmaceuticals Price Performance , Royal Bank , Verrica Pharmaceuticals , News Ratings For Verrica Pharmaceuticals Daily , Jefferies Financial Group , Verrica Pharmaceuticals Inc , Dimensional Fund Advisors , Get Rating , Street Corp , Systematic Strategies , Fund Advisors , Financial Group , Matthew Davidson , West Chester , Visit Holdingschannel , Verrica Pharmaceuticals Daily , Nasdaq Vrca , Vrca , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,